9-22447159-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022160.3(DMRTA1):āc.94T>Cā(p.Ser32Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000843 in 1,601,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022160.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMRTA1 | NM_022160.3 | c.94T>C | p.Ser32Pro | missense_variant | 1/2 | ENST00000325870.3 | NP_071443.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMRTA1 | ENST00000325870.3 | c.94T>C | p.Ser32Pro | missense_variant | 1/2 | 1 | NM_022160.3 | ENSP00000319651.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000158 AC: 35AN: 220996Hom.: 0 AF XY: 0.000179 AC XY: 22AN XY: 122708
GnomAD4 exome AF: 0.0000814 AC: 118AN: 1448946Hom.: 0 Cov.: 30 AF XY: 0.0000985 AC XY: 71AN XY: 720726
GnomAD4 genome AF: 0.000112 AC: 17AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2022 | The c.94T>C (p.S32P) alteration is located in exon 1 (coding exon 1) of the DMRTA1 gene. This alteration results from a T to C substitution at nucleotide position 94, causing the serine (S) at amino acid position 32 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at